<p>Chi-square test was performed to compare the clinical feature.</p><p>*, Hyperglycemia group versus Euglycemia group and Uncontrolled group versus Controlled group: <i>P</i><0.05, respectively.</p
<p>Results are n (%) and were compared between groups by Chi-square test or Fisher's exact test if a...
<p>HR, hazard ratio; CI, confidence interval;</p>*<p>Statistically significant (P<0.05).</p
*<p> Logrank <i>P</i>-value for the differences in survival.</p>†<p> Median survival upper limit not...
<p><sup>a</sup>Continuous variables were expressed as median (interquartile) and categorical variabl...
We determined 13 markers of pancreatic cancer which are used presently and tried quantitative combin...
<p>In all the panels, each circle represents a measurement for one patient. Levels of each parameter...
<p><sup><i>#</i></sup><i>P</i><0.05 vs. SO group; <sup>★</sup><i>P</i><0.05 vs. SAP group.</p
<p>TS: Treated Scenario; NS: Normal Scenario; PC: Pancreatic Cancer Scenario. The green arrow heads ...
(a) Distribution of the PRS in pancreatic cancer case and control subjects. (b) The OR for pancreati...
<p>Comparison of variants detected in plasma and tumor tissue from 10 patients with pancreatic cance...
Comparison of demographics, comorbid conditions and clinical symptoms of patients classified by panc...
Comparison of clinical outcomes from previous studies of fractionated SBRT for locally advanced panc...
Introduction: In some patients with chronic pancreatitis, the diagnosis of pancreatic cancer can be ...
Variations in the reporting of potentially confounding variables in studies investigating systemic t...
<p>Comparison of weight and height SDS between untreated (no pancreatic enzyme supplementation) subc...
<p>Results are n (%) and were compared between groups by Chi-square test or Fisher's exact test if a...
<p>HR, hazard ratio; CI, confidence interval;</p>*<p>Statistically significant (P<0.05).</p
*<p> Logrank <i>P</i>-value for the differences in survival.</p>†<p> Median survival upper limit not...
<p><sup>a</sup>Continuous variables were expressed as median (interquartile) and categorical variabl...
We determined 13 markers of pancreatic cancer which are used presently and tried quantitative combin...
<p>In all the panels, each circle represents a measurement for one patient. Levels of each parameter...
<p><sup><i>#</i></sup><i>P</i><0.05 vs. SO group; <sup>★</sup><i>P</i><0.05 vs. SAP group.</p
<p>TS: Treated Scenario; NS: Normal Scenario; PC: Pancreatic Cancer Scenario. The green arrow heads ...
(a) Distribution of the PRS in pancreatic cancer case and control subjects. (b) The OR for pancreati...
<p>Comparison of variants detected in plasma and tumor tissue from 10 patients with pancreatic cance...
Comparison of demographics, comorbid conditions and clinical symptoms of patients classified by panc...
Comparison of clinical outcomes from previous studies of fractionated SBRT for locally advanced panc...
Introduction: In some patients with chronic pancreatitis, the diagnosis of pancreatic cancer can be ...
Variations in the reporting of potentially confounding variables in studies investigating systemic t...
<p>Comparison of weight and height SDS between untreated (no pancreatic enzyme supplementation) subc...
<p>Results are n (%) and were compared between groups by Chi-square test or Fisher's exact test if a...
<p>HR, hazard ratio; CI, confidence interval;</p>*<p>Statistically significant (P<0.05).</p
*<p> Logrank <i>P</i>-value for the differences in survival.</p>†<p> Median survival upper limit not...
DOI
Add to ORKG